End-of-day quote
Other stock markets
|
||
- HKD | - |
Apr. 17 | BeiGene to Award Shares Worth $15 Million to 11 Directors | MT |
Apr. 11 | Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech | MT |
Sales 2024 * | 3.08B 24.13B | Sales 2025 * | 3.93B 30.74B | Capitalization | 13.79B 108B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.99B | Net income 2025 * | -358M -2.8B | EV / Sales 2024 * | 3.99 x |
Net cash position 2024 * | 1.48B 11.61B | Net cash position 2025 * | 1.13B 8.86B | EV / Sales 2025 * | 3.22 x |
P/E ratio 2024 * |
-15.4
x | P/E ratio 2025 * |
-40.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
+0.59% | 13.4B | |
+20.86% | 11.06B | |
-21.69% | 8.88B |